{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:35:25Z","timestamp":1773920125631,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The etiological factors of Cholestatic Liver Diseases especially primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are not fully illustrated. It has been reported in previous observational studies that gut microbiota are associated with cholestatic liver diseases. However, there is uncertainty regarding the causality of this association. By using Mendelian randomization, this study aimed to examine the causal impact of gut microbiota on cholestatic liver diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From large-scale genome-wide association studies, genetic instruments for each gut microbiota taxa as well as primary biliary cholangitis and primary sclerosing cholangitis were developed. Subsequently, we conducted a two-sample Mendelian randomization analysis, supplemented by multiple <jats:italic>post hoc<\/jats:italic> sensitivity analyses. Additionally, we performed reverse MR analyses to investigate the possibility of the reverse causal association.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>This two-sample MR study indicated that the <jats:italic>order Bacillales, family Peptostreptococcaceae, family Ruminococcaceae, genus Anaerotruncu<\/jats:italic> was associated with a decreased risk of developing PBC, and that <jats:italic>order Selenomonadales, family Bifidobacteriaceae<\/jats:italic> may be factors that increase the risk of PBC. On the other hand, we also identified <jats:italic>order Selenomonadales, family Rhodospirillaceae, and genus RuminococcaceaeUCG013<\/jats:italic> were positively associated with PSC. The <jats:italic>order Actinomycetales, family Actinomycetaceae, genus Actinomyces, genus Alloprevotella, genus Barnesiella<\/jats:italic>, and <jats:italic>genus Peptococcus<\/jats:italic> were found negative associations with the risk of PSC. The reverse MR analysis demonstrated no statistically significant relationship between PBC, PSC and these specific gut microbial taxa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings offered novel evidence that the abundance of particular bacteria contributes to the risk of PBC and PSC, which may contribute to more effective approaches to PBC and PSC therapy and prevention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1342119","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:35:01Z","timestamp":1706070901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study"],"prefix":"10.3389","volume":"11","author":[{"given":"Jiaqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/hep.32437","article-title":"Cholestatic liver diseases of genetic etiology: advances and controversies","volume":"75","author":"Ibrahim","year":"2022","journal-title":"Hepatol Baltim Md"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.cgh.2022.10.032","article-title":"GLIMMER: a randomized phase 2b dose-ranging trial of Linerixibat in primary biliary cholangitis patients with pruritus","volume":"21","author":"Levy","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2022.02.033","article-title":"A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis","volume":"77","author":"Bowlus","year":"2022","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.14309\/ajg.0000000000002128","article-title":"Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis","volume":"118","author":"de Veer","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/apt.16023","article-title":"Review article: pathophysiology and management of primary biliary cholangitis","volume":"52","author":"Leung","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1115014","DOI":"10.3389\/fmicb.2023.1115014","article-title":"Roles of gut microbiome in epilepsy risk: a Mendelian randomization study","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1087622","DOI":"10.3389\/fmicb.2023.1087622","article-title":"Assessment of causal associations among gut microbiota, metabolites, and celiac disease: a bidirectional Mendelian randomization study","volume":"14","author":"Li","year":"2023","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"921546","DOI":"10.3389\/fimmu.2022.921546","article-title":"Two-sample Mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative colitis or Crohn\u2019s disease","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","article-title":"Ecological and evolutionary forces shaping microbial diversity in the human intestine","volume":"124","author":"Ley","year":"2006","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.5604\/01.3001.0010.5672","article-title":"The role of bile acids in glucose metabolism and their relation with diabetes","volume":"16","author":"Gonz\u00e1lez-Regueiro","year":"2017","journal-title":"Ann Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e0198757","DOI":"10.1371\/journal.pone.0198757","article-title":"Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease","volume":"13","author":"Abe","year":"2018","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/EDE.0000000000000699","article-title":"Nature as a Trialist?: deconstructing the analogy between Mendelian randomization and randomized trials","volume":"28","author":"Swanson","year":"2017","journal-title":"Epidemiol Camb Mass"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"key":"ref25","first-page":"269","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume-title":"Nat Genet","author":"Ji","year":"2017"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/ebmental-2019-300085","article-title":"Using Mendelian randomisation to assess causality in observational studies","volume":"22","author":"Pagoni","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1273024","DOI":"10.3389\/fmicb.2023.1273024","article-title":"Causal associations between gut microbiota and primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1099\/ijs.0.013102-0","article-title":"Negativicoccus succinicivorans gen. Nov., sp. nov., isolated from human clinical samples, emended description of the family Veillonellaceae and description of Negativicutes classis nov., Selenomonadales Ord. Nov. and Acidaminococcaceae fam. Nov. in the bacterial phylum Firmicutes","volume":"60","author":"Marchandin","year":"2010","journal-title":"Int J Syst Evol Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/JCM.43.11.5721-5732.2005","article-title":"Defining the normal bacterial flora of the oral cavity","volume":"43","author":"Aas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.3390\/biomedicines10123272","article-title":"Ruminococcaceae_UCG-013 promotes obesity resistance in mice","volume":"10","author":"Feng","year":"2022","journal-title":"Biomedicine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41564-021-00970-4","article-title":"Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut","volume":"6","author":"Laursen","year":"2021","journal-title":"Nat Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.mi.21.100167.000443","article-title":"Biology of actinomycetes","volume":"21","author":"Lechevalier","year":"1967","journal-title":"Annu Rev Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1124\/dmd.115.065698","article-title":"Review: mechanisms of how the intestinal microbiota alters the effects of drugs and bile acids","volume":"43","author":"Klaassen","year":"2015","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","article-title":"The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?","volume":"99","author":"Stilling","year":"2016","journal-title":"Neurochem Int"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5935\/1808-8694.20140031","article-title":"Peripheral Th17\/Treg cell-mediated immunity imbalance in allergic rhinitis patients","volume":"80","author":"Huang","year":"2014","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1600-065x.1999.tb01363.x","article-title":"Processing of bacterial antigens for peptide presentation on MHC class I molecules","volume":"172","author":"Wick","year":"1999","journal-title":"Immunol Rev"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.vaccine.2005.01.106","article-title":"Bacterial derived proteoliposome as ideal delivery system and cellular adjuvant","volume":"24","author":"Rodr\u00edguez","year":"2006","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/hep.31724","article-title":"Enoxacin up-regulates MicroRNA biogenesis and Down-regulates cytotoxic CD8 T-cell function in autoimmune cholangitis","volume":"74","author":"Itoh","year":"2021","journal-title":"Hepatol Baltim Md."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J Lipid Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat Metab"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"980768","DOI":"10.3389\/fimmu.2022.980768","article-title":"HLA, gut microbiome and hepatic autoimmunity","volume":"13","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/apt.14397","article-title":"Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease","volume":"47","author":"Woodhouse","year":"2018","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1342119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:35:05Z","timestamp":1706070905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1342119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":47,"alternative-id":["10.3389\/fmed.2024.1342119"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1342119","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"article-number":"1342119"}}